Jerome J Schentag, Pharm.D.

Vice President of Translational Research & Partner

Jerome is an Inventor and Chief Executive Officer of TheraSyn an IP holding company with his 85 granted and published patents. Currently Emeritus Professor of Pharmacy at the University of Buffalo, NY, Prof Schentag has 40+ years of US and Global Translational Pharmacology expertise in Infectious Diseases, Critical Care, Sepsis, Metabolic Syndrome, and oncology. He developed and applied PK/PD modeling to antimicrobials over many years, eventually leading to these principles as a core principle of antibiotic development and marketing. He has deep expertise in drug delivery systems, starting with the invention of the SmartPill, a medical device for diagnosis of GI tract malfunction and the predicate device for the characterization of the ileal Brake. He is the Co-inventor of Brake™, the first oral mimetic of RYGB Bariatric surgery and its associated cure of Type 2 Diabetes and Metabolic syndrome. Dr. Schentag and colleagues have used the teachings of the SmartPill to invent a practical means of oral absorption and intracellular delivery of peptides, proteins and other macromolecules. This is the only known means of converting these otherwise injectable biologicals into a practical form for regular use. . He is also a co-inventor on microbiome delivery systems to the colon and ileum vaccination for both infectious disease and immuno-oncology. Prof Schentag’s research in immuno-oncology has recently characterized Myocarditis associated with checkpoint inhibitors in oncology, and he is currently studying Myocarditis associated with Covid-19 and Covid-19 vaccines. Further information on Patents is available at http://www.schentag.com/ Dr Schentag’s entrepreneurial experience comprises several private equity investments and exit transactions across a broad spectrum in healthcare. He obtained his Pharm.D. at the Philadelphia College of Pharmacy & Science, followed by postdoctoral fellowship training in the clinical applications of Pharmacokinetics and Pharmacodynamics at the University of Buffalo.